MedPath

Breast Cancer Detection: Comparison of Breast Tomosynthesis and Conventional Mammography

Not Applicable
Completed
Conditions
Breast Cancer
Interventions
Device: Tomosynthesis
Device: Conventional
Registration Number
NCT01669148
Lead Sponsor
Massachusetts General Hospital
Brief Summary

The primary hypothesis to be tested is:

The detection of breast cancer will be increased with tomosynthesis (3D) imaging

Detailed Description

The purpose of this study is to determine if: 1 the detection of breast cancer will be increased with conventional (2D) imaging plus tomosynthesis (3D) imaging, or 2. if the the detection of breast cancer will be increased with tomosynthesis (3D) imaging alone.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
496
Inclusion Criteria
  • Female
  • Any ethnic origin
  • No contraindication for routine bilateral mammography
Exclusion Criteria

Potential subjects with any of the following will not be enrolled in the study:

  • Any contraindications to mammographic screening, including, but not limited to:

  • Significant existing breast trauma

  • Under the age of 30 at the time of consent

  • Breast Implants

  • Prior Surgeries

    • Unable to understand and execute written informed consent
    • Pregnant
    • Lactating

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Tomosynthesis aloneTomosynthesistomosynthesis (3D) imaging alone first then conventional (2D) imaging plus tomosyntheis 1 month later.
Conventional + TomosynthesisConventionalconventional (2D) imaging plus tomosynthesis (3D) imaging first then tomosynthesis alone 1 month later.
Conventional + TomosynthesisTomosynthesisconventional (2D) imaging plus tomosynthesis (3D) imaging first then tomosynthesis alone 1 month later.
Primary Outcome Measures
NameTimeMethod
Detection of Breast Cancer (Sensitivity)up to two years follow up for development of breast cancer

Sensitivity is the number of true positives (TP) divided by the sum of TP and false negatives (FN):

Sensitivity = TP / (TP+FN)

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

MGH

🇺🇸

Boston, Massachusetts, United States

© Copyright 2025. All Rights Reserved by MedPath